These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15924883)

  • 21. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA; Orphanides G; Moggs JG
    Reprod Toxicol; 2005; 20(3):433-40. PubMed ID: 15964738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
    Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
    Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET; Zira AN; Theocharis SE
    J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin.
    Cheng SL; Liu RH; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
    J Biomed Sci; 2007 Jan; 14(1):87-105. PubMed ID: 17103032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicogenomics in drug development.
    Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
    Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA microarrays as a tool in toxicogenomics.
    de Longueville F; Bertholet V; Remacle J
    Comb Chem High Throughput Screen; 2004 May; 7(3):207-11. PubMed ID: 15134526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicogenomics screening of small molecules using high-density, nanocapillary real-time PCR.
    Vass L; Kelemen JZ; Fehér LZ; Lorincz Z; Kulin S; Cseh S; Dormán G; Puskás LG
    Int J Mol Med; 2009 Jan; 23(1):65-74. PubMed ID: 19082508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The next innovation cycle in toxicogenomics: environmental epigenetics.
    Reamon-Buettner SM; Mutschler V; Borlak J
    Mutat Res; 2008; 659(1-2):158-65. PubMed ID: 18342568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microarrays demystified.
    Medlin J
    Environ Health Perspect; 2004 Mar; 112(4):A222-3. PubMed ID: 15033604
    [No Abstract]   [Full Text] [Related]  

  • 30. The usefulness of toxicogenomics for predicting acute skin irritation on in vitro reconstructed human epidermis.
    Borlon C; Godard P; Eskes C; Hartung T; Zuang V; Toussaint O
    Toxicology; 2007 Nov; 241(3):157-66. PubMed ID: 17928126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.
    Fostel JM
    Pharmacogenomics; 2007 May; 8(5):425-30. PubMed ID: 17465705
    [No Abstract]   [Full Text] [Related]  

  • 32. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V; Le Fevre AC; Boitier E
    Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicogenomics and studies of genomic effects of dietary components.
    Thompson K
    World Rev Nutr Diet; 2010; 101():115-122. PubMed ID: 20436258
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.
    Li HH; Aubrecht J; Fornace AJ
    Mutat Res; 2007 Oct; 623(1-2):98-108. PubMed ID: 17548094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.
    Pennie W; Pettit SD; Lord PG
    Environ Health Perspect; 2004 Mar; 112(4):417-9. PubMed ID: 15033589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicogenomics in biomarker discovery.
    Decristofaro MF; Daniels KK
    Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced oxidative stress in rat liver from a toxicogenomics perspective.
    McMillian M; Nie A; Parker JB; Leone A; Kemmerer M; Bryant S; Herlich J; Yieh L; Bittner A; Liu X; Wan J; Johnson MD; Lord P
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):171-8. PubMed ID: 15982685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putting the fun into functional toxicogenomics.
    Cunningham ML
    Toxicol Sci; 2006 Aug; 92(2):347-8. PubMed ID: 16883652
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing chronic liver toxicity based on relative gene expression data.
    Kulkarni K; Larsen P; Linninger AA
    J Theor Biol; 2008 Sep; 254(2):308-18. PubMed ID: 18585395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.